| Selenium accumulation and metabolism in algae M Schiavon, A Ertani, S Parrasia, F Dalla Vecchia Aquatic Toxicology 189, 1-8, 2017 | 128 | 2017 |
| Strategies to target bioactive molecules to subcellular compartments. Focus on natural compounds L Biasutto, A Mattarei, M La Spina, M Azzolini, S Parrasia, I Szabo, ... European journal of medicinal chemistry 181, 111557, 2019 | 23 | 2019 |
| Insight into the mechanism of cytotoxicity of membrane-permeant psoralenic Kv1. 3 channel inhibitors by chemical dissection of a novel member of the family R Peruzzo, A Mattarei, M Azzolini, KA Becker-Flegler, M Romio, G Rigoni, ... Redox biology 37, 101705, 2020 | 22 | 2020 |
| Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges S Parrasia, I Szabò, M Zoratti, L Biasutto Molecular Pharmaceutics 19 (11), 3700-3729, 2022 | 21 | 2022 |
| Browning effects of a chronic pterostilbene supplementation in mice fed a high-fat diet M La Spina, E Galletta, M Azzolini, S Gomez Zorita, S Parrasia, ... International Journal of Molecular Sciences 20 (21), 5377, 2019 | 20 | 2019 |
| Small-molecule modulators of mitochondrial channels as chemotherapeutic agents S Parrasia, A Mattarei, A Furlan, M Zoratti, L Biasutto Cellular Physiology and Biochemistry 53 (S1), 11-43, 2019 | 11 | 2019 |
| An Angiopep2-PAPTP Construct Overcomes the Blood-Brain Barrier. New Perspectives against Brain Tumors S Parrasia, A Rossa, T Varanita, V Checchetto, R De Lorenzi, M Zoratti, ... Pharmaceuticals 14 (2), 129, 2021 | 9 | 2021 |
| Targeting pancreatic ductal adenocarcinoma (pdac) S Parrasia, M Zoratti, I Szabò, L Biasutto Cell Physiol Biochem 55, 61-90, 2021 | 9 | 2021 |
| Multiple mechanisms converging on transcription factor EB activation by the natural phenol pterostilbene M La Spina, M Azzolini, A Salmaso, S Parrasia, E Galletta, M Schiavone, ... Oxidative Medicine and Cellular Longevity 2021 (1), 7658501, 2021 | 6 | 2021 |
| 4-hydroxy-3, 5-pyridinedicarboxylic acids: synthesis, complexation properties towards Fe (III), Al (III), Cu (II), Zn (II), human serum albumin, and cellular toxicity A Dean, MG Ferlin, D Carta, T Jakusch, T Kiss, FF Faccioli, S Parrasia, ... Journal of Solution Chemistry 47, 92-106, 2018 | 2 | 2018 |
| Mitochondrial permeability transition pore: a snapshot of a therapeutic target M Zoratti, L Biasutto, S Parrasia, I Szabo Expert Opinion on Therapeutic Targets, 1-3, 2024 | 1 | 2024 |
| DA7R: a 7-letter Zip code to target PDAC S Parrasia, A Rossa, N Roncaglia, A Mattarei, C Honisch, I Szabò, ... Pharmaceutics 15 (5), 1508, 2023 | 1 | 2023 |
| Long-Term Pterostilbene Supplementation of a High-Fat Diet Increases Adiponectin Expression in the Subcutaneous White Adipose Tissue S Parrasia, E Galletta, M La Spina, A Magrini, M Azzolini, M Salvalaio, ... Nutraceuticals 2 (2), 102-115, 2022 | 1 | 2022 |
| Corrigendum to “Insight into the mechanism of cytotoxicity of membrane-permeant psoralenic Kv1. 3 channel inhibitors by chemical dissection of a novel member of the family … R Peruzzo, A Mattarei, M Azzolini, KA Becker-Flegler, M Romio, G Rigoni, ... Redox Biology 45, 2021 | 1 | 2021 |
| N-palmitoyl-D-glucosamine in a micronized form F Della Valle, MF Della Valle, G Marcolongo, S Parrasia, S Cuzzocrea US Patent 11,744,840, 2023 | | 2023 |
| Pharmacological profile of the most promising CFTR corrector for sarcoglycanopathy treatment. A Benetollo, M Scano, S Parrasia, L Biasutto, FD Barba, P Caccin, ... European Journal of Translational Myology 33 (2), 2023 | | 2023 |
| Composti naturali e loro derivati nella salute e nelle patologie S Parrasia Università degli studi di Padova, 2022 | | 2022 |
| C17 corrector for the treatment of sarcoglycanopathy: preliminary ADME studies A Benetollo, M Scano, S Parrasia, L Biasutto, F DALLA BARBA, P Caccin, ... National Ph. D. Meeting, Salerno, Italy 24-26 March 2022, 2022 | | 2022 |
| Insight into the mechanism of cytotoxicity of membrane-permeant psoralenic Kv1. 3 channel inhibitors by chemical dissection of a novel member of the family (vol 37, 101705, 2020) R Peruzzo, A Mattarei, M Azzolini, KA Becker-Flegler, M Romio, G Rigoni, ... REDOX BIOLOGY 45, 2021 | | 2021 |
| Conjugation with Angiopep2 as a strategy for the brain delivery of a mitochondriotropic inhibitor of the potassium channel Kv1. 3 S Parrasia, A Rossa, T Varanita, R De Lorenzi, M Zoratti, C Paradisi, ... MDPI, 2020 | | 2020 |
